TrialBlood cancer journal2017

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.

L Lopes-Aguiar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.